Wolverine Asset Management LLC Purchases 72,601 Shares of abrdn Life Sciences Investors $HQL

Wolverine Asset Management LLC boosted its position in shares of abrdn Life Sciences Investors (NYSE:HQL) by 50.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 215,521 shares of the company’s stock after purchasing an additional 72,601 shares during the quarter. Wolverine Asset Management LLC owned about 0.75% of abrdn Life Sciences Investors worth $3,343,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Penserra Capital Management LLC raised its stake in shares of abrdn Life Sciences Investors by 3.0% during the second quarter. Penserra Capital Management LLC now owns 769,657 shares of the company’s stock worth $9,859,000 after buying an additional 22,736 shares during the last quarter. Raymond James Financial Inc. raised its position in shares of abrdn Life Sciences Investors by 20.3% during the 2nd quarter. Raymond James Financial Inc. now owns 375,960 shares of the company’s stock valued at $4,816,000 after acquiring an additional 63,429 shares during the last quarter. Flagship Harbor Advisors LLC raised its position in shares of abrdn Life Sciences Investors by 0.3% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 341,959 shares of the company’s stock valued at $4,380,000 after acquiring an additional 1,082 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of abrdn Life Sciences Investors by 21.7% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 235,499 shares of the company’s stock valued at $3,017,000 after purchasing an additional 42,015 shares during the period. Finally, Shaker Financial Services LLC boosted its position in shares of abrdn Life Sciences Investors by 536.8% in the 3rd quarter. Shaker Financial Services LLC now owns 197,804 shares of the company’s stock worth $3,068,000 after purchasing an additional 166,742 shares during the last quarter. Institutional investors own 32.21% of the company’s stock.

abrdn Life Sciences Investors Trading Down 0.1%

NYSE HQL opened at $16.59 on Friday. The stock has a 50-day simple moving average of $16.99 and a 200 day simple moving average of $15.37. abrdn Life Sciences Investors has a 12 month low of $10.55 and a 12 month high of $17.80.

abrdn Life Sciences Investors Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, January 12th. Stockholders of record on Friday, November 21st were paid a $0.50 dividend. This is a boost from abrdn Life Sciences Investors’s previous quarterly dividend of $0.42. The ex-dividend date of this dividend was Friday, November 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 12.1%.

abrdn Life Sciences Investors Company Profile

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.